1 POSTS 10 COMMENTSErica Rex writes about science, environment, mental health, climate, and the forces shaping all of them. She’s written for The New York Times, Scientific American, The Times (UK) among many other publications, and is the recipient of a National Magazine Award. She was a subject in one of the first clinical trials using psilocybin to treat cancer related depression in 2012. Her book-in-progress traces the story of psychedelics through the lens of her quest to heal from childhood trauma. Ms. Rex’s unique perspective shows how psychedelic medicine can provide a pathway out of trauma, a light at the end of a very long tunnel, but it is not without risks.